Celiac Disease Drugs Market 2017-2021 : Radiant Insights


Posted July 14, 2017 by MarketResearchReport

The report covers the present scenario and the growth prospects of the global celiac disease drugs market for 2017-2021.
 
Celiac disease is an autoimmune inflammatory disease of the small intestine, which is triggered by intake of gluten from wheat and other sources through our food. Presently, there is no specific drug approved for celiac disease, and the first line of treatment is completely dominated by a gluten-free diet. There are few anti-inflammatory and immunosuppressant drugs and nutritional supplements that are used as off-label therapy in celiac disease. All these off-label therapies are considered as second-line of treatment.

Radiant Insights analysts forecast the global celiac disease drugs market to grow at a CAGR of 24.22% during the period 2017-2021.

Download Full Research Report: http://www.radiantinsights.com/research/global-celiac-disease-drugs-market-2017-2021

The report covers the present scenario and the growth prospects of the global celiac disease drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
•Americas
•APAC
•EMEA

Global Celiac Disease Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
•F. Hoffmann-La Roche
•Johnson & Johnson
•Merck
•Pfizer

Other prominent vendors
•ADMA Biologics
•Amgen
•Anthera Pharmaceuticals
•Bayer
•Biogen
•BioLineRx
•Biotest
•Bristol-Myers Squibb
•Celgene
•Celimmune
•ImmunogenX
•Immunomedics
•ImmusanT
•Innovate Biopharmaceuticals
•Kedrion Biopharma
•LFB Group
•Novartis
•Shire
•Takeda Pharmaceutical

Request a Free Sample Copy of this Report: http://www.radiantinsights.com/research/global-celiac-disease-drugs-market-2017-2021/request-sample

Market driver
• Prevalence of disease
• For a full, detailed list, view our report

Market challenge
• Long-term sustainability
• For a full, detailed list, view our report

Market trend
• Inorganic growth strategies
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

See More Reports of This Category by Radiant Insights:
http://www.radiantinsights.com/catalog/healthcare

About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Priya Sharma
Website Radiant Insights, Inc
Phone 1-888-202-9519
Business Address 28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Country United States
Categories Health
Tags celiac disease drugs , celiac disease drugs market
Last Updated July 14, 2017